Hereditary Hemorrhagic Telangiectasia Latest Advances

Pulmonary arteriovenous malformation (PAVM) with hereditary haemorrhagic telangiectasia (HHT): a rare cause of paradoxical embolic stroke.

Journal: BMJ case reports

Published: September 01, 2026

Atypical Presentation of Hereditary Hemorrhagic Telangiectasia Without Recurrent Epistaxis Leading to Delayed Diagnosis.

Journal: The American journal of case reports

Published: August 26, 2026

Verifying genetic diagnoses: Hereditary hemorrhagic telangiectasia - juvenile polyposis syndrome (HHT-JPS) or familial adenomatous polyposis (FAP)?

Journal: Clinical and investigative medicine. Medecine clinique et experimentale

Published: August 26, 2026

Hereditary haemorrhagic telangiectasia presenting with refractory gastrointestinal bleeding.

Journal: BMJ case reports

Published: August 18, 2026

Targeting KIT prevents brain arteriovenous malformations driven by ALK1-deficient angiogenic endothelial cells.

Journal: The Journal of clinical investigation

Published: August 11, 2026

Two Roads to a Shunt: Distinct Endothelial Programs in SMAD4 and ALK1 Loss-of-Function Explain Hereditary Hemorrhagic Telangiectasia Syndrome Diversity.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: August 06, 2026

Corrigendum to "Epistaxis burden in hereditary hemorrhagic telangiectasia: Validation and refinement of the NOSE-HHT" [Am J Otolaryngol Head Neck Med Surg 47 (2026) 104876].

Journal: American journal of otolaryngology

Published: July 28, 2026

Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations.

Journal: American journal of hematology

Published: July 18, 2026

Gene-Specific Endothelial Programs Drive AVM Pathogenesis in SMAD4 and ALK1 Loss-of-Function.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 16, 2026

Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population-based registry study.

Journal: Journal of internal medicine

Published: July 07, 2026

Patients with hereditary hemorrhagic telangiectasia have significantly reduced overall survival-And likely by a greater magnitude than we realize.

Journal: Journal of internal medicine

Published: July 03, 2026

Pulmonary Arteriovenous Malformation Misdiagnosed As Chronic Obstructive Pulmonary Disease: A Case Report.

Journal: Cureus

Published: June 28, 2026

Hereditary Hemorrhagic Telangiectasia Latest Advances

Find the Latest Research About Hereditary Hemorrhagic Telangiectasia

Pulmonary arteriovenous malformation (PAVM) with hereditary haemorrhagic telangiectasia (HHT): a rare cause of paradoxical embolic stroke.

Pulmonary arteriovenous malformation (PAVM) with hereditary haemorrhagic telangiectasia (HHT): a rare cause of paradoxical embolic stroke.

Atypical Presentation of Hereditary Hemorrhagic Telangiectasia Without Recurrent Epistaxis Leading to Delayed Diagnosis.

Atypical Presentation of Hereditary Hemorrhagic Telangiectasia Without Recurrent Epistaxis Leading to Delayed Diagnosis.

Verifying genetic diagnoses: Hereditary hemorrhagic telangiectasia - juvenile polyposis syndrome (HHT-JPS) or familial adenomatous polyposis (FAP)?

Verifying genetic diagnoses: Hereditary hemorrhagic telangiectasia - juvenile polyposis syndrome (HHT-JPS) or familial adenomatous polyposis (FAP)?

Hereditary haemorrhagic telangiectasia presenting with refractory gastrointestinal bleeding.

Hereditary haemorrhagic telangiectasia presenting with refractory gastrointestinal bleeding.

Targeting KIT prevents brain arteriovenous malformations driven by ALK1-deficient angiogenic endothelial cells.

Targeting KIT prevents brain arteriovenous malformations driven by ALK1-deficient angiogenic endothelial cells.

Two Roads to a Shunt: Distinct Endothelial Programs in SMAD4 and ALK1 Loss-of-Function Explain Hereditary Hemorrhagic Telangiectasia Syndrome Diversity.

Two Roads to a Shunt: Distinct Endothelial Programs in SMAD4 and ALK1 Loss-of-Function Explain Hereditary Hemorrhagic Telangiectasia Syndrome Diversity.

Corrigendum to "Epistaxis burden in hereditary hemorrhagic telangiectasia: Validation and refinement of the NOSE-HHT" [Am J Otolaryngol Head Neck Med Surg 47 (2026) 104876].

Corrigendum to "Epistaxis burden in hereditary hemorrhagic telangiectasia: Validation and refinement of the NOSE-HHT" [Am J Otolaryngol Head Neck Med Surg 47 (2026) 104876].

Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations.

Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations.

Gene-Specific Endothelial Programs Drive AVM Pathogenesis in SMAD4 and ALK1 Loss-of-Function.

Gene-Specific Endothelial Programs Drive AVM Pathogenesis in SMAD4 and ALK1 Loss-of-Function.

Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population-based registry study.

Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population-based registry study.

Patients with hereditary hemorrhagic telangiectasia have significantly reduced overall survival-And likely by a greater magnitude than we realize.

Patients with hereditary hemorrhagic telangiectasia have significantly reduced overall survival-And likely by a greater magnitude than we realize.

Pulmonary Arteriovenous Malformation Misdiagnosed As Chronic Obstructive Pulmonary Disease: A Case Report.

Pulmonary Arteriovenous Malformation Misdiagnosed As Chronic Obstructive Pulmonary Disease: A Case Report.